The evolutionary old forebrain as site of action to develop new psychotropic drugs
Anton J. M. Loonen, Svetlana А. Ivanova
Journal of Psychopharmacology September 26, 2018 DOI: 10.1177/0269881118798617 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Interventions | Ketamine Varenicline |
| Dose | subanaesthetic dosages |
| Citations | 39 |
| Key points | Argues that the forebrain is organized in three evolutionarily layered systems, with the primary layer's habenula-projecting pallidum neurons regulating dopamine pathways and proposed as a target of subanaesthetic ketamine, and the medial habenula linking nicotinergic signaling to adrenergic and serotonergic activity, possibly connecting varenicline-induced hostility to SSRI-induced aggression. |
Abstract
Background: Previously, the authors have developed a model of how reward-seeking and distress- avoiding behaviour is regulated by the human brain. The forebrain's evolution in vertebrates was taken as a starting point.
Aims: The authors want to inspire colleagues to study in particular the pharmacological effects on the described ancient forebrain structures in order to modify specific symptoms of mental disorders.
Methods: Compilation of data and ideas of previous articles, with examples to illustrate.
Results: A primary (lamprey-like), secondary (frog-like) and tertiary (mammal-like) forebrain can be distinguished, organized according to a Russian doll model. The first constituent is primarily involved in producing the emotional response, while the last is principally concerned with constructing conscious cognitive behaviour (including verbal and written communication). Mental disorders comprise (partly related and partly unrelated) biological and rational phenomena. The secondary system regulates the intensity of reward-seeking and distress-avoiding behaviour. An essential component of the primary forebrain evaluates the results of behavioural actions: the lateral habenula-projecting pallidum. These neurons regulate the activity of ascending dopaminergic pathways. The authors suggest that these habenula-projecting pallidum neurons are targeted by subanaesthetic dosages of ketamine. The medial habenula is enriched with nicotinergic acetylcholine receptors and regulates the activity of ascending adrenergic and serotonergic neurons. This may link varenicline-induced hostility to selective serotonin reuptake inhibitor-induced aggression.
Conclusions: Studying the effects of new compounds on the primary and secondary brains in lampreys and frogs may yield interesting new treatments of mental disorders.
Citations in the library
Cites 5
- Mechanisms of Ketamine Action as an Antidepressant Molecular Psychiatry March 13, 2018
- Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency? The Journal of Clinical Psychiatry July 20, 2017
- Ketamine for Depression, 3: Does Chirality Matter? The Journal of Clinical Psychiatry June 27, 2017
- Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature Harvard Review of Psychiatry February 20, 2018
- Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action. The Journal of Clinical Psychiatry April 2017